Cell therapy weekly: job losses at Lonza and positive results in stage IV pancreas cancer
This week: autologous therapies shown to safe and tolerated in pancreatic cancer and type 1 diabetes trials, and new biopharma will develop candidate from MD Anderson Cancer Center.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>